This session will focus on controversies in the understanding of the pathogenesis of pulmonary arterial hypertension (PAH). By employing a pro-con debate style, this session will critically evaluate opposing views of how pulmonary hypertension and right heart failure develops, identify points of agreement and disagreement with the ultimate goal to reach a consensus to identify novel treatment targets for PAH.